canstaging.org

What It Is

CanStaging+ is a cancer staging tool developed collaboratively by Northern Ireland Cancer Registry, IARC, UICC, and Cancer Council Queensland. Its goal is to improve the availability, standardization, and comparability of international cancer staging information, mainly for use in cancer registration, public health research, and oncology data management.

Core Features and Professional Scope

The tool can automatically calculate TNM 7th and 8th edition stages, and also supports Essential TNM. For adult cancers, it covers breast, cervix, liver, lung, oesophagus, ovary, pancreas, prostate, stomach, cutaneous melanoma, and more; for colorectal cancer, it supports TNM 5th and 8th editions. It also supports paediatric cancer staging based on the Toronto Paediatric Cancer Staging Guidelines, covering 15 types of childhood cancers. The text also references functional entry points such as Sites, Help, Register, Feedback, Changelog, and Log in.

Pricing, Open Source, and Deployment

The main text does not disclose any commercial plans, subscription pricing, payment methods, or trial period. Notably, the CanStaging+ source code is copyright IARC 2021 and released under the GNU/GPL license; its business rules files are released under Creative Commons BY-SA. This suggests potential for open use and secondary deployment, but the page does not provide clear self-hosting deployment documentation, cloud service SLAs, or enterprise procurement information.

Integrations, Collaboration, and Security

From an enterprise software perspective, disclosure is limited. The main text does not mention APIs, SDKs, bulk data interfaces, or third-party system integrations, nor does it describe collaboration capabilities such as team workspaces, role-based permissions, or audit logs. On security and compliance, there is no visible information about encryption, privacy compliance, or certifications. The page explicitly states that the tool is provided “as is” and accepts no liability for errors, omissions, or consequences of use. As such, it is better understood as a professional rules calculator rather than a complete medical SaaS platform.

Pros, Cons, and Who It’s For

Its strengths are that the rule sources are clear, based on UICC TNM, Essential TNM, and the Toronto paediatric cancer guidelines, with participation from multiple authoritative organizations. It is well suited to cancer registries, researchers, and public health projects that need a consistent staging framework. Its limitations are the lack of enterprise-grade product information and the recommendation to use it together with the UICC TNM classification books, which creates a relatively high barrier for general users.

Access from China and Alternatives

Access from mainland China is not stated in the main text and should be considered unknown; payment information is also not disclosed. If access is restricted or localization is required, alternatives include UICC TNM resources, the original Toronto guideline rules, or tumour staging modules within domestic hospital or cancer registry systems.